Short CommunicationDifferential effects of psychostimulants and related agents on dopaminergic and serotonergic transporter function
Introduction
This laboratory has reported that both a single and multiple administrations of methamphetamine cause a rapid and reversible decrease in striatal dopamine transporter activity; effects attributable to decreases in Vmax of transport Fleckenstein et al., 1997b, Kokoshka et al., 1998b. These transient decreases do not reflect loss and subsequent replacement of dopamine transporters, since: (1) methamphetamine does not cause an acute loss of transporter protein (Kokoshka et al., 1998b); and (2) the time necessary to recover transporter function (<1 day) is much less than that likely required to synthesize dopamine transporters de novo (the t1/2 for dopamine transporter turnover is ≈6 days; Fleckenstein et al., 1996). Moreover, these decreases are not due to the direct effects of residual methamphetamine introduced by the original subcutaneous (s.c.) injection Fleckenstein et al., 1997b, Kokoshka et al., 1998b. Instead, we believe that these rapid and reversible effects of methamphetamine provide evidence of a previously uncharacterized mechanism whereby transporter activity can be modulated rapidly in vivo.
Recent evidence suggests that dopamine contributes to the acute decrease in dopamine transporter function following multiple administrations of methamphetamine since this effect is attenuated by prior dopamine depletion with the tyrosine hydroxylase inhibitor, α-methyl-para-tyrosine (Metzger et al., 1998b). Consistent with this finding, direct application of dopamine to striatal synaptosomal preparations decreases dopamine transporter activity (Berman et al., 1996). Since many psychostimulants alter dopamine uptake and release, it might be expected that these, too, might effect the rapid and reversible decrease in dopamine transporter activity caused by methamphetamine. Hence, the purpose of this study was to determine whether other psychostimulants and related agents alter dopamine transporter function. Since methamphetamine effects a rapid and reversible decrease in serotonin transporter function as well (Kokoshka et al., 1998a), effects on serotonin uptake were also assessed. For comparison, effects on dopamine and serotonin uptake after direct application of psychostimulant or related agent of interest to striatal synaptosomes in vitro were also assessed since these assays are employed commonly to predict effects of these agents on transporter function in vivo. The results reveal differential effects of psychostimulants on dopamine and serotonin transporter function, and indicate that the capacity of a compound to alter monoamine uptake in vitro does not predict its potential to modulate monoamine transporters after administration in vivo.
Section snippets
Animals
Male Sprague–Dawley rats (250–300 g; Simonsen Laboratories, Gilroy, CA) were housed at 23°C with a alternating light/dark cycle (lights on 14 h/day). Food and water were provided ad libitum. Rats were sacrificed by decapitation. All experiments were conducted in accordance with National Institute of Health guidelines.
Drugs and chemicals
[7,8-3H]Dopamine (46 Ci/mmol) was purchased from Amersham Life Sciences (Arlington Heights, IL). 5-[1,2-3H(N)]-hydroxytryptamine (30 Ci/mmol) was purchased from New England Nuclear
Results
We reported previously that a single administration of methamphetamine, methylenedioxymethamphetamine or methcathinone decreased striatal [3H]dopamine uptake to 63%–72% of control values in striatal synaptosomes prepared 1 h after drug administration (Metzger et al., 1998a). Results presented in Table 1 demonstrate that high-dose administration of cathinone or amphetamine decreased [3H]dopamine uptake as well (i.e., to 78% and 80% of control values, respectively). In contrast, a single
Discussion
Recent evidence has suggested that dopamine is necessary for the rapid and reversible decrease in dopamine transporter function caused by multiple injections of methamphetamine (Metzger et al., 1998b). This may be due to findings that dopamine promotes the formation of oxygen radicals (Graham, 1978) which can oxidize and inactivate dopamine transporters Berman et al., 1996, Fleckenstein et al., 1997a. Consistent with this hypothesis, direct application of dopamine to striatal synaptosomal
Acknowledgements
This research was supported by PHS grants DA 00869, DA 04222, DA 11389 and DA 00378.
References (20)
- et al.
Characterization of methylphenidate and nomifensine induced dopamine release in rat striatum using in vivo brain microdialysis
Neurosci. Lett.
(1991) - et al.
Oxygen radicals diminish dopamine transporter function in rat striatum
Eur. J. Pharmacol.
(1997) - et al.
Enantiomeric differences in the effects of 3,4-methylenedioxymethampethamine on extracellular monoamines and metabolites in the striatum of freely-moving rats: an in vivo microdialysis study
Neuropharmacology
(1990) - et al.
In vivo neurochemical profile of dopamine uptake inhibitors and releasers in rat caudate–putamen
Eur. J. Pharmacol.
(1989) - et al.
Methamphetamine treatment rapidly inhibits serotonin, but not glutamate, transporters in rat brain
Brain Res.
(1998) - et al.
Nature of methamphetamine-induced rapid and reversible changes in dopamine transporters in rat brain
Eur. J. Pharmacol.
(1998) - et al.
Methylenedioxymethamphetamine-induced acute changes in dopamine transporter function
Eur. J. Pharmacol.
(1998) - et al.
Protein kinase C-mediated phosphorylation and functional regulation in striatal synaptosomes
Biol. Chem.
(1997) - et al.
Modification of dopamine transporter functions: effect of reactive oxygen species and dopamine
J. Neurochem.
(1996) - et al.
Protein kinase C activators decrease dopamine uptake into striatal synaptosomes
J. Pharmacol. Exp. Ther.
(1996)